Literature DB >> 29055105

Characteristics of chronic lymphocytic leukemia patients achieving 5+ years of remission after FC-based first-line treatment: Retrospective observations from the FILO group.

Yann Guillermin1,2, Charles Herbaux3, Fabien Subtil4, Thérèse Aurran-Schleinitz5, Florence Cymbalista6, Remi Letestu6, Stéphane Leprêtre7, Sandrine Vaudaux7, Kamel Laribi8, Véronique Leblond9, Yasmina Defoi9, Raouf Benchikh9, Gilles Salles2,3,4,5,6,7,8,9,10, Pascal Godmer11, Henry Jardel11, Fréderic Vallais11, Pierre Feugier12, Frédérique Orsini13, Brigitte Pegourié14, Vincent Lévy5, Anne-Sophie Michallet1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29055105     DOI： 10.1002/ajh.24951

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  1 in total

1.  Severe infections in patients with lymphoproliferative diseases treated with new targeted drugs: A multicentric real-world study.

Authors:  Maria Stefania Infante; Ana Fernández-Cruz; Lucia Núñez; Cecilia Carpio; Ana Jiménez-Ubieto; Javier López-Jiménez; Lourdes Vásquez; Raquel Del Campo; Samuel Romero; Carmen Alonso; Daniel Morillo; Margarita Prat; José Luis Plana; Paola Villafuerte; Gabriela Bastidas; Ana Bocanegra; Ángel Serna; Rodrigo De Nicolás; Juan Marquet; Carmen Mas-Ochoa; Raúl Cordoba; Julio García-Suárez; Alessandra Comai; Xavier Martín; Mariana Bastos-Oreiro; Cristina Seri; Belén Navarro-Matilla; Armando López-Guillermo; Joaquín Martínez-López; José Ángel Hernández-Rivas; Isabel Ruiz-Camps; Carlos Grande
Journal:  Cancer Med       Date:  2021-09-23       Impact factor: 4.452
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.